WO2007016405A3 - Devices, articles, coatings, and methods for controlled active agent release or hemocompatibility - Google Patents
Devices, articles, coatings, and methods for controlled active agent release or hemocompatibility Download PDFInfo
- Publication number
- WO2007016405A3 WO2007016405A3 PCT/US2006/029555 US2006029555W WO2007016405A3 WO 2007016405 A3 WO2007016405 A3 WO 2007016405A3 US 2006029555 W US2006029555 W US 2006029555W WO 2007016405 A3 WO2007016405 A3 WO 2007016405A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- active agent
- copolymer
- articles
- devices
- methods
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title abstract 7
- 238000000034 method Methods 0.000 title abstract 3
- 238000000576 coating method Methods 0.000 title abstract 2
- 229920001577 copolymer Polymers 0.000 abstract 7
- 239000000203 mixture Substances 0.000 abstract 4
- 229920005604 random copolymer Polymers 0.000 abstract 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D133/00—Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Coating compositions based on derivatives of such polymers
- C09D133/04—Homopolymers or copolymers of esters
- C09D133/14—Homopolymers or copolymers of esters of esters containing halogen, nitrogen, sulfur or oxygen atoms in addition to the carboxy oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/06—Use of macromolecular materials
- A61L33/064—Use of macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
Abstract
The present invention relates to devices, articles, coatings, and methods for controlled active agent release and/or for providing a hemocompatible surface. More specifically, the present invention relates to copolymer compositions and devices, articles, and methods regarding the same for controlled active agent release. In an embodiment, the present invention includes a copolymer composition. The copolymer composition can include a copolymer and an active agent. In an embodiment, the copolymer includes an effective portion of a monomelic unit including a polar moiety. The active agent can be polar. The active agent can be charged. The active agent can be non-polar. In an embodiment, the copolymer composition includes a random copolymer. In an embodiment, the random copolymer includes butyl methacrylate-co-acrylamido-methyl-propane sulfonate copolymer, which can provide reduced platelet adhesion.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06800498.5A EP1912684B1 (en) | 2005-07-29 | 2006-07-27 | Devices, articles, coatings, and methods for controlled active agent release or hemocompatibility |
JP2008524219A JP2009502355A (en) | 2005-07-29 | 2006-07-27 | Devices, products, coatings and methods for controlled active agent release or blood compatibility |
CA002616959A CA2616959A1 (en) | 2005-07-29 | 2006-07-27 | Devices, articles, coatings, and methods for controlled active agent release or hemocompatibility |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70355505P | 2005-07-29 | 2005-07-29 | |
US60/703,555 | 2005-07-29 | ||
US73342305P | 2005-11-03 | 2005-11-03 | |
US60/733,423 | 2005-11-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007016405A2 WO2007016405A2 (en) | 2007-02-08 |
WO2007016405A3 true WO2007016405A3 (en) | 2007-07-12 |
Family
ID=37709234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/029555 WO2007016405A2 (en) | 2005-07-29 | 2006-07-27 | Devices, articles, coatings, and methods for controlled active agent release or hemocompatibility |
Country Status (5)
Country | Link |
---|---|
US (1) | US8663673B2 (en) |
EP (1) | EP1912684B1 (en) |
JP (1) | JP2009502355A (en) |
CA (1) | CA2616959A1 (en) |
WO (1) | WO2007016405A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9155671B2 (en) | 2012-10-16 | 2015-10-13 | Surmodics, Inc. | Wound packing device and methods |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7611533B2 (en) * | 1995-06-07 | 2009-11-03 | Cook Incorporated | Coated implantable medical device |
US7431710B2 (en) | 2002-04-08 | 2008-10-07 | Glaukos Corporation | Ocular implants with anchors and methods thereof |
US20070212397A1 (en) * | 2005-09-15 | 2007-09-13 | Roth Daniel B | Pharmaceutical delivery device and method for providing ocular treatment |
US8968782B2 (en) * | 2006-06-28 | 2015-03-03 | Surmodics, Inc. | Combination degradable and non-degradable matrices for active agent delivery |
US8685421B2 (en) * | 2006-07-07 | 2014-04-01 | Surmodics, Inc. | Beaded wound spacer device |
US20080171087A1 (en) * | 2006-08-16 | 2008-07-17 | Chappa Ralph A | Methods and materials for increasing the adhesion of elution control matrices to substrates |
WO2008039749A2 (en) * | 2006-09-25 | 2008-04-03 | Surmodics, Inc. | Multi-layered coatings and methods for controlling elution of active agents |
WO2008088593A2 (en) * | 2006-09-27 | 2008-07-24 | Surmodics, Inc. | Additives and methods for enhancing active agent elution kinetics |
JP2010512225A (en) * | 2006-12-12 | 2010-04-22 | ボーシュ アンド ローム インコーポレイティド | Regular polymer systems and intraocular lenses |
US8182829B2 (en) * | 2007-07-27 | 2012-05-22 | Abbott Cardiovascular Systems Inc. | Drug eluting implantable medical device with hemocompatible and/or prohealing topcoat |
TR201820076T4 (en) * | 2007-08-16 | 2019-01-21 | Biocompatibles Uk Ltd | Release of drug combinations. |
US20090214601A1 (en) * | 2007-09-28 | 2009-08-27 | Chappa Ralph A | Porous Drug Delivery Devices and Related Methods |
US20090202609A1 (en) * | 2008-01-06 | 2009-08-13 | Keough Steven J | Medical device with coating composition |
US20090186059A1 (en) * | 2008-01-14 | 2009-07-23 | Johnson Elizabeth E | Devices and methods for elution of nucleic acid delivery complexes |
WO2009126830A2 (en) * | 2008-04-09 | 2009-10-15 | Surmodics, Inc. | Delivery of nucleic acid complexes from materials including negatively charged groups |
US8936811B2 (en) * | 2008-05-07 | 2015-01-20 | Surmodics, Inc. | Device coated with glycogen particles comprising nucleic acid complexes |
EP2306929A1 (en) * | 2008-07-14 | 2011-04-13 | SurModics, Inc. | Medical devices and methods for delivery of nucleic acids |
DE102008038368A1 (en) * | 2008-08-19 | 2010-02-25 | Biotronik Vi Patent Ag | Use of organic gold complexes as bioactive and radioopaque stent coating for permanent and degradable vascular implants |
US8623395B2 (en) | 2010-01-29 | 2014-01-07 | Forsight Vision4, Inc. | Implantable therapeutic device |
CA2757037C (en) | 2009-01-29 | 2019-08-06 | Forsight Vision4, Inc. | Posterior segment drug delivery |
WO2010118238A2 (en) * | 2009-04-08 | 2010-10-14 | Surmodics, Inc. | Controlled release devices and methods for delivery of nucleic acids |
US8883208B2 (en) * | 2009-04-08 | 2014-11-11 | Surmodics, Inc. | Particles for delivery of nucleic acids and related devices and methods |
US8246576B2 (en) | 2009-05-18 | 2012-08-21 | Surmodics, Inc. | Method and apparatus for delivery of a therapeutic agent with an expandable medical device |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
US10166142B2 (en) | 2010-01-29 | 2019-01-01 | Forsight Vision4, Inc. | Small molecule delivery with implantable therapeutic device |
EP3375446B1 (en) | 2010-04-13 | 2020-04-08 | KCI Licensing, Inc. | Compositions with reactive ingredients, and wound dressings, apparatuses, and methods |
US20110319473A1 (en) | 2010-06-29 | 2011-12-29 | Surmodics, Inc. | Compositions and methods for enhancement of nucleic acid delivery |
RS62540B1 (en) | 2010-08-05 | 2021-12-31 | Forsight Vision4 Inc | Apparatus to treat an eye |
RS61601B1 (en) | 2010-08-05 | 2021-04-29 | Forsight Vision4 Inc | Injector apparatus for drug delivery |
AU2011285548B2 (en) | 2010-08-05 | 2014-02-06 | Forsight Vision4, Inc. | Combined drug delivery methods and apparatus |
AU2011329656B2 (en) | 2010-11-19 | 2017-01-05 | Forsight Vision4, Inc. | Therapeutic agent formulations for implanted devices |
US8901092B2 (en) | 2010-12-29 | 2014-12-02 | Surmodics, Inc. | Functionalized polysaccharides for active agent delivery |
US20130041203A1 (en) * | 2011-02-18 | 2013-02-14 | Marlin Stephen Heilman | Blood flow assist devices, systems and methods |
US10213529B2 (en) | 2011-05-20 | 2019-02-26 | Surmodics, Inc. | Delivery of coated hydrophobic active agent particles |
US9861727B2 (en) | 2011-05-20 | 2018-01-09 | Surmodics, Inc. | Delivery of hydrophobic active agent particles |
US9120040B2 (en) * | 2011-05-26 | 2015-09-01 | The University Of Akron | Anti-fouling materials based on poly(β-peptoid)s |
US10245178B1 (en) | 2011-06-07 | 2019-04-02 | Glaukos Corporation | Anterior chamber drug-eluting ocular implant |
EP2726016B1 (en) | 2011-06-28 | 2023-07-19 | ForSight Vision4, Inc. | An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye |
WO2013040247A2 (en) | 2011-09-16 | 2013-03-21 | Forsight Vision4, Inc. | Fluid exchange apparatus and methods |
WO2013116061A1 (en) | 2012-02-03 | 2013-08-08 | Forsight Vision4, Inc. | Insertion and removal methods and apparatus for therapeutic devices |
WO2014071387A1 (en) | 2012-11-05 | 2014-05-08 | Surmodics, Inc. | Composition and method for delivery of hydrophobic active agents |
US11246963B2 (en) | 2012-11-05 | 2022-02-15 | Surmodics, Inc. | Compositions and methods for delivery of hydrophobic active agents |
CA2905496A1 (en) | 2013-03-14 | 2014-09-25 | Forsight Vision4, Inc. | Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant |
AU2014241163B2 (en) | 2013-03-28 | 2018-09-27 | Forsight Vision4, Inc. | Ophthalmic implant for delivering therapeutic substances |
WO2015184173A1 (en) | 2014-05-29 | 2015-12-03 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
WO2016011191A1 (en) | 2014-07-15 | 2016-01-21 | Forsight Vision4, Inc. | Ocular implant delivery device and method |
US10201457B2 (en) | 2014-08-01 | 2019-02-12 | Surmodics, Inc. | Wound packing device with nanotextured surface |
SG11201700943TA (en) | 2014-08-08 | 2017-03-30 | Forsight Vision4 Inc | Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof |
CA2967330A1 (en) | 2014-11-10 | 2016-05-19 | Forsight Vision4, Inc. | Expandable drug delivery devices and methods of use |
WO2017040853A1 (en) | 2015-09-02 | 2017-03-09 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
JP6823875B2 (en) | 2015-09-15 | 2021-02-03 | サベージ メディカル, インコーポレイテッド | Devices and methods for mooring sheaths in tissue cavities |
US11564833B2 (en) | 2015-09-25 | 2023-01-31 | Glaukos Corporation | Punctal implants with controlled drug delivery features and methods of using same |
CN113069681B (en) | 2015-11-20 | 2022-12-23 | 弗赛特影像4股份有限公司 | Method of manufacturing a therapeutic device for sustained drug delivery |
ES2837524T3 (en) | 2016-04-05 | 2021-06-30 | Forsight Vision4 Inc | Implantable ocular drug delivery devices |
WO2017184881A1 (en) | 2016-04-20 | 2017-10-26 | Harold Alexander Heitzmann | Bioresorbable ocular drug delivery device |
US10898446B2 (en) | 2016-12-20 | 2021-01-26 | Surmodics, Inc. | Delivery of hydrophobic active agents from hydrophilic polyether block amide copolymer surfaces |
CN111655206B (en) | 2017-11-21 | 2022-10-14 | 弗赛特影像4股份有限公司 | Fluid exchange device for expandable port delivery system and method of use |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0942003A1 (en) * | 1998-03-09 | 1999-09-15 | National Starch and Chemical Investment Holding Corporation | Pressure sensitive adhesive with allyl amine moiety |
WO2000040628A1 (en) * | 1998-12-30 | 2000-07-13 | The B.F. Goodrich Company | Branched/block copolymers for treatment of keratinous substrates |
EP1026219A1 (en) * | 1999-02-02 | 2000-08-09 | First Water Limited | Bioadhesive compositions |
WO2001083866A2 (en) * | 2000-05-04 | 2001-11-08 | Kimberly-Clark Worldwide, Inc. | Salt-sensitive, water-dispersible polymer composition |
WO2006116348A2 (en) * | 2005-04-26 | 2006-11-02 | Advanced Cardiovascular Systems, Inc. | Compositions for medical devices containing agent combinations in controlled volumes |
WO2006121669A2 (en) * | 2005-05-05 | 2006-11-16 | Boston Scientific Limited | Coating of medical devices with solids |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4638045A (en) | 1985-02-19 | 1987-01-20 | Massachusetts Institute Of Technology | Non-peptide polyamino acid bioerodible polymers |
DE69231073T2 (en) * | 1991-10-24 | 2001-02-15 | Insutech Inc | INFUSION SYSTEM DRIVEN BY GAS PRESSURE GENERATED BY HYDROGEL BY ELECTROLYSIS |
JP3455217B2 (en) | 1992-02-13 | 2003-10-14 | バイオ−メトリック システムズ インコーポレイテッド | Immobilization of chemical species in crosslinked matrix |
US5344455A (en) | 1992-10-30 | 1994-09-06 | Medtronic, Inc. | Graft polymer articles having bioactive surfaces |
US5788687A (en) | 1994-02-01 | 1998-08-04 | Caphco, Inc | Compositions and devices for controlled release of active ingredients |
US5466233A (en) | 1994-04-25 | 1995-11-14 | Escalon Ophthalmics, Inc. | Tack for intraocular drug delivery and method for inserting and removing same |
US5840387A (en) | 1995-07-28 | 1998-11-24 | Aegis Biosciences L.L.C. | Sulfonated multiblock copolymer and uses therefor |
US6110483A (en) | 1997-06-23 | 2000-08-29 | Sts Biopolymers, Inc. | Adherent, flexible hydrogel and medicated coatings |
WO1999055396A1 (en) | 1998-04-27 | 1999-11-04 | Surmodics, Inc. | Bioactive agent release coating |
US20020188037A1 (en) | 1999-04-15 | 2002-12-12 | Chudzik Stephen J. | Method and system for providing bioactive agent release coating |
US6306419B1 (en) | 2000-02-23 | 2001-10-23 | Aegis Biosciences, Llc | Medical uses of styrene sulfonate polymers |
MXPA03001406A (en) | 2000-08-15 | 2004-05-04 | Surmodics Inc | Medicament incorporation matrix. |
DE60135352D1 (en) | 2000-08-30 | 2008-09-25 | Univ Johns Hopkins | DEVICE FOR INTRA-OCCULAR ACTIVE AGGREGATION |
ATE506929T1 (en) | 2001-06-12 | 2011-05-15 | Univ Johns Hopkins Med | RESERVOIR DEVICE FOR INTRAOCULAR MEDICINAL DELIVERY |
WO2003030879A1 (en) | 2001-10-05 | 2003-04-17 | Surmodics, Inc. | Particle immobilized coatings and uses thereof |
CA2498489C (en) | 2002-09-29 | 2010-02-23 | Surmodics, Inc. | Method for subretinal administration of therapeutics including steroids;method for localizing pharmacodynamic action at the choroid and the retina; and related methods for treatment and/or prevention of retinal diseases |
US20040142910A1 (en) | 2002-10-21 | 2004-07-22 | Aegis Biosciences Llc | Sulfonated styrene copolymers for medical uses |
ATE476960T1 (en) | 2003-05-02 | 2010-08-15 | Surmodics Inc | SYSTEM FOR THE CONTROLLED RELEASE OF A BIOACTIVE INGREDIENT IN THE BACK OF THE EYE |
US20060110428A1 (en) | 2004-07-02 | 2006-05-25 | Eugene Dejuan | Methods and devices for the treatment of ocular conditions |
US7771740B2 (en) * | 2004-07-19 | 2010-08-10 | Boston Scientific Scimed, Inc. | Medical devices containing copolymers with graft copolymer endblocks for drug delivery |
-
2006
- 2006-07-26 US US11/493,346 patent/US8663673B2/en not_active Expired - Fee Related
- 2006-07-27 WO PCT/US2006/029555 patent/WO2007016405A2/en active Application Filing
- 2006-07-27 CA CA002616959A patent/CA2616959A1/en not_active Abandoned
- 2006-07-27 JP JP2008524219A patent/JP2009502355A/en active Pending
- 2006-07-27 EP EP06800498.5A patent/EP1912684B1/en not_active Not-in-force
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0942003A1 (en) * | 1998-03-09 | 1999-09-15 | National Starch and Chemical Investment Holding Corporation | Pressure sensitive adhesive with allyl amine moiety |
WO2000040628A1 (en) * | 1998-12-30 | 2000-07-13 | The B.F. Goodrich Company | Branched/block copolymers for treatment of keratinous substrates |
EP1026219A1 (en) * | 1999-02-02 | 2000-08-09 | First Water Limited | Bioadhesive compositions |
WO2001083866A2 (en) * | 2000-05-04 | 2001-11-08 | Kimberly-Clark Worldwide, Inc. | Salt-sensitive, water-dispersible polymer composition |
WO2006116348A2 (en) * | 2005-04-26 | 2006-11-02 | Advanced Cardiovascular Systems, Inc. | Compositions for medical devices containing agent combinations in controlled volumes |
WO2006121669A2 (en) * | 2005-05-05 | 2006-11-16 | Boston Scientific Limited | Coating of medical devices with solids |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9155671B2 (en) | 2012-10-16 | 2015-10-13 | Surmodics, Inc. | Wound packing device and methods |
Also Published As
Publication number | Publication date |
---|---|
EP1912684B1 (en) | 2014-03-05 |
WO2007016405A2 (en) | 2007-02-08 |
US20070026037A1 (en) | 2007-02-01 |
CA2616959A1 (en) | 2007-02-08 |
US8663673B2 (en) | 2014-03-04 |
EP1912684A2 (en) | 2008-04-23 |
JP2009502355A (en) | 2009-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007016405A3 (en) | Devices, articles, coatings, and methods for controlled active agent release or hemocompatibility | |
WO2009064879A3 (en) | Antimicrobial coatings for medical devices and methods for making and using them | |
WO2009047269A3 (en) | Use of highly functional, highly branched polyetheramine polyols for coating surfaces | |
WO2007130734A3 (en) | Antimicrobial coating | |
SI1709125T1 (en) | Coating composition having surface depolluting properties | |
WO2009125222A3 (en) | Antimicrobial system | |
WO2006042116A3 (en) | Aluminum phosphate compositions, coatings and related composites | |
WO2007077560A3 (en) | Cryoprotective compositions and methods of using same | |
WO2008022803A3 (en) | Extrusion coated substrate | |
WO2007140375A3 (en) | Methods and systems for selectively depositing si-containing films using chloropolysilanes | |
WO2007130838A3 (en) | Coating compositions exhibiting corrosion resistance properties, related coated articles and methods | |
WO2009048645A3 (en) | Lipid coatings for implantable medical devices | |
WO2007070649A3 (en) | Antimicrobial coating system | |
WO2006124365A3 (en) | Endothelial cell binding coatings for rapid encapsulation of bioerodable stents | |
WO2006031965A3 (en) | Controlled release antimicrobial polymer compositions | |
WO2006074391A3 (en) | Biodegradable coating compositions comprising blends | |
WO2007019439A3 (en) | Block copolymer compositions and uses thereof | |
EP1803754A3 (en) | Biologically active block copolymers, coating compositions and coated articles thereof | |
WO2008128028A3 (en) | Solifenacin compositions | |
WO2008024509A3 (en) | Cationic latex as a carrier for bioactive ingredients and methods for making and using the same | |
EP1939935A3 (en) | Indium Compositions | |
WO2007095258A3 (en) | Rhamnolipid compositions and related methods of use | |
MXPA03001299A (en) | Coating compositions for adhesion to olefinic substrates. | |
WO2006060468A3 (en) | Rubber formulation and methods for manufacturing same | |
JP2009529356A5 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref document number: 2616959 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008524219 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006800498 Country of ref document: EP |